Drug Approval | June 17, 2024
Alembic announces USFDA final approval for Icatibant injection
This is the first peptide product approval from the USFDA received by Alembic Pharmaceuticals
This is the first peptide product approval from the USFDA received by Alembic Pharmaceuticals
Establishing Asymchem’s first manufacturing footprint in Europe
EBITDA for the quarter stood at Rs 964 crore, representing an EBITDA margin of 24%
Biocon will undertake the development, manufacturing and supply of the drug product, and Biomm will be responsible for obtaining regulatory approval and commercialization in the Brazilian market
Liraglutide is a drug-device combination formulation used in the treatment of Type 2 Diabetes Mellitus
Acquisition to further expand the Alexion, AstraZeneca Rare Disease pipeline beyond complement inhibition
Liraglutide belongs to the class of glucagon like peptide 1 receptor agonist (GLP?1 RA) drugs
Express Scripts to add Zepbound to National Preferred Formulary
Final stage in licensing OVM-200 from Oxford Vacmedix in the UK
The product will be manufactured at Lupin’s Nagpur facility in India
Subscribe To Our Newsletter & Stay Updated
